SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-021159
Filing Date
2024-05-07
Accepted
2024-05-07 16:47:59
Documents
70
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q abcl-20240331.htm   iXBRL 10-Q 1238218
2 EX-31.1 abcl-20240331xexx311.htm EX-31.1 10406
3 EX-31.2 abcl-20240331xexx312.htm EX-31.2 10369
4 EX-32.1 abcl-20240331xexx321.htm EX-32.1 4766
5 EX-32.2 abcl-20240331xexx322.htm EX-32.2 4743
11 abcl-20240331_g1.jpg GRAPHIC 99927
  Complete submission text file 0001628280-24-021159.txt   5671080

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abcl-20240331.xsd EX-101.SCH 43914
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abcl-20240331_cal.xml EX-101.CAL 71430
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abcl-20240331_def.xml EX-101.DEF 162348
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abcl-20240331_lab.xml EX-101.LAB 527222
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abcl-20240331_pre.xml EX-101.PRE 341892
74 EXTRACTED XBRL INSTANCE DOCUMENT abcl-20240331_htm.xml XML 547425
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39781 | Film No.: 24922822
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)